April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

January 19, 2022

The recent surge in COVID-19 is driving the number of cases to record highs in the course of the pandemic. The impact is being felt at area hospitals who continue to battle the pandemic. In a story published by WKRC-TV, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, said that the surge is putting a lot of stress on healthcare providers.

October 11, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources cited in an article in Medscape on pharmaceutical company Merck developing a new pill for COVID-19. Fichtenbaum said it wasn't a 'home run' but it was encouraging.

November 18, 2021

COVID-19 cases in the region are rising just ahead of the Thanksgiving holiday. Health experts are concerned about people getting together for the holidays, especially for certain groups. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, was one of the experts interviewed for a story produced by WLWT-TV.

January 11, 2022

With COVID-19 cases surging thanks to the omicron variant, many people are turning to self-administered tests to see if they have the virus. Some who do their own research about the tests online, may find a wide variety of theories on the best way to administer the tests. In an article published by Cincinnati.com, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine answers some questions about how to make the most of a home COVID-19 test.

January 3, 2022

Jennifer Wall Forrester, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by NPR for a story on the impact the latest COVID-19 surge is having on hospitalizations in Ohio.

January 4, 2022

With COVID-19 cases surging in Ohio at the close of 2021, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was quoted in an article in Newsweek urging people not to attend New Year's Eve parties.

September 29, 2021

Several companies, including Pfizer are developing a pill to fight COVID-19 symptoms. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WKRC-TV, Local12 for a story about the antiviral medications and explained how they work.

October 8, 2021

Carl Fichtenbaum, MD, and Jennifer Forrester, MD, both of the Division of Infectious Diseases at the UC College of Medicine were interviewed for a story posted on Cincinnati.com on what experts would advise parents to do in regards to handing out candy on Halloween.

October 29, 2021

The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.